Compare CNC & MDLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CNC | MDLN |
|---|---|---|
| Founded | 1984 | 1966 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 33.5B | 37.4B |
| IPO Year | 2001 | 2025 |
| Metric | CNC | MDLN |
|---|---|---|
| Price | $66.05 | $35.59 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 16 | 23 |
| Target Price | $46.75 | ★ $50.48 |
| AVG Volume (30 Days) | 4.1M | ★ 6.8M |
| Earning Date | 04-28-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 5.30 | 0.23 |
| Revenue | ★ $194,777,000,000.00 | $28,432,000,000.00 |
| Revenue This Year | $8.31 | $10.88 |
| Revenue Next Year | $1.05 | $7.69 |
| P/E Ratio | ★ $12.66 | $154.35 |
| Revenue Growth | ★ 19.44 | 11.47 |
| 52 Week Low | $27.76 | $32.82 |
| 52 Week High | $69.36 | $50.88 |
| Indicator | CNC | MDLN |
|---|---|---|
| Relative Strength Index (RSI) | 53.00 | 43.56 |
| Support Level | $63.20 | $34.32 |
| Resistance Level | $68.39 | $37.79 |
| Average True Range (ATR) | 3.13 | 1.67 |
| MACD | 0.19 | -0.45 |
| Stochastic Oscillator | 79.51 | 31.48 |
Centene is a managed care organization that focuses on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges. Centene served 20 million medical members as of December 2025, mostly in Medicaid (about 64% of membership), the individual exchanges (about 28%), and Medicare (about 5%). The company also provides Medicare Part D pharmaceutical plans.
Medline is the largest medical-surgical products and supply chain solutions provider in the US. The company generates over 90% of its revenue domestically and serves some of the largest US health systems. Medline offers approximately 190,000 Medline-branded products across more than 250 product families—including front line care, surgical solutions, and laboratory and diagnostics—as well as roughly 150,000 third-party products sourced from over 1,250 vendors. The company maintains prime vendor relationships with many customers, acting as the primary consolidated logistics partner for their medical-surgical needs. Medline has significant scale, supported by more than 30 manufacturing facilities and a fleet of over 2,000 owned delivery trucks. Medline went public in December 2025.